{"id":5912,"date":"2025-08-07T23:03:34","date_gmt":"2025-08-07T23:03:34","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/08\/07\/readout-loud-podcast-third-harmonic-eli-lilly-obesity-vertex-pain-biotech\/"},"modified":"2025-08-07T23:03:34","modified_gmt":"2025-08-07T23:03:34","slug":"readout-loud-podcast-third-harmonic-eli-lilly-obesity-vertex-pain-biotech","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/08\/07\/readout-loud-podcast-third-harmonic-eli-lilly-obesity-vertex-pain-biotech\/","title":{"rendered":"Closing a zombie biotech, and Lilly\u2019s disappointing obesity readout"},"content":{"rendered":"<p>    Closing a zombie biotech, and Lilly\u2019s disappointing obesity readout<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>How does a biotech company decide to shut itself down? Why does Eli Lilly have so much riding on its oral obesity candidate? And what\u2019s the outlook for Vertex\u2019s pain franchise?<\/p>\n<p>We discuss that and more on this on this week\u2019s episode of \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We bring on Natalie Holles, who was the CEO of Third Harmonic Bio, which recently decided to dissolve and return cash to shareholders. She walks us through why the company has decided to do this and her advice for other biotech CEOs.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/08\/07\/readout-loud-podcast-third-harmonic-eli-lilly-obesity-vertex-pain-biotech\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Adam Feuerstein, Elaine Chen, and Allison DeAngelis<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/08\/07\/readout-loud-podcast-third-harmonic-eli-lilly-obesity-vertex-pain-biotech\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Closing a zombie biotech, and Lilly\u2019s disappointing obesity readout How does a biotech company decide to shut itself down? Why does Eli Lilly have so much riding on its oral obesity candidate? And what\u2019s the outlook for Vertex\u2019s pain franchise? We discuss that and more on this on this week\u2019s episode of \u201cThe Readout LOUD,\u201d [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2594,2282,3414,2265,2566],"tags":[2150],"class_list":["post-5912","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-eli-lilly","category-obesity","category-pain","category-the-readout-loud","category-vertex","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5912"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=5912"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5912\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=5912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=5912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=5912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}